Gene therapy

#Cell therapy #Drug development #Drug discovery #Drug targets #Gene therapy #Lead discovery #Oncology #RNA #Stem cells #System biology #Therapeutics

Grey Wolf completes financing to accelerate development of ERAP2 therapies

Grey Wolf Therapeutics completes £2.5 million ($3.3 million) Series A2 financing to accelerate development of therapies targeting ERAP2. Grey Wolf targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumors for attack and destruction by the immune system. Grey Wolf Therapeutics, a drug discovery… Read More

#News

#Biochemistry #Cell therapy #Cellular & Molecular biology #Chemistry #Clinical specialities #Drug development #Drug discovery #Gene therapy #Lead discovery #RNA #Therapeutics

Enterprise Therapeutics publishes paper on novel cystic fibrosis approach

Enterprise Therapeutics publishes paper on novel therapeutic approach for treatment of all cystic fibrosis patients. Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering with respiratory disease, today announced the publication of… Read More

#News

#Biologics / Biotechnology #Cell therapy #Clinical specialities #Clinical trials #Drug development #Drug discovery #Gene therapy #Immunology #Immunology / Virology & Vaccines #Pathology #Preclinical #RNA

NIH-Moderna investigational COVID-19 vaccine shows promise in mouse studies

The vaccine is currently being evaluated in Phase 3 clinical testing. The investigational vaccine known as mRNA-1273 protected mice from infection with SARS-CoV-2, the virus that causes COVID-19, according to research published today in Nature. Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the… Read More

#Covid-19 #News

#AI / data analytics / healthtech / informatics #Analysis #Assay development optimisation & technology #Automation / robotics #Cell therapy #Drug development #Drug discovery #Gene therapy #Immunology #Lead discovery #Oncology #Pathology #Precision medicine #RNA #Screening #Stem cells #Therapeutics

Researchers discover cell communication mechanism that drives cancer adaptation

Collaborative Cancer Research UK-funded studies from University of Oxford researchers have uncovered a new mechanism by which cancer cells adapt to the stresses they encounter as they grow and respond to therapies. This mechanism involves cells releasing small vesicles, known as exosomes. These contain complex mixtures of proteins,… Read More

#Cancer Research #Covid-19 #News

#Academic #Biologics / Biotechnology #Business #Cell culture #Cell therapy #Gene therapy #Microfluidics

Technology developed to rapidly scale up cell and gene therapy manufacture

Image: ThisisEngineering RAEng CPI, MicrofluidX and the Cell and Gene Therapy Catapult (CGT Catapult) have collaborated in a project to develop bioprocessing technology for the rapid scale-up of cell and gene therapies. The technology has the potential to overcome a major bottleneck in the development of these novel… Read More

#News

#AI / data analytics / healthtech / informatics #Business #Computational chemistry #Drug development #Drug discovery #Drug targets #Gene therapy #Molecular medicine #Orphan drugs #Precision medicine

Centogene and Molecular Health collaborate to develop orphan drugs

Image: Fabio Centogene and Molecular Health, are to collaborate on the Real-life data and Innovative Bioinformatic Algorithms (RIBA) project, starting with epilepsy as the first indication. RIBA aims to foster a unique novel precision medicine environment to accelerate, de-risk, and improve the development of new orphan drugs based… Read More

#News

#Biologics / Biotechnology #Clinical trials #Drug development #Drug discovery #Gene therapy #Immunology / Virology & Vaccines #Lead discovery #Regulatory #RNA

Phase III clinical trial of investigational vaccine for COVID-19 begins in US

Multi-site trial to test candidate developed by Moderna and NIH. A Phase III clinical trial designed to evaluate if an investigational vaccine can prevent symptomatic coronavirus disease 2019 (COVID-19) in adults has begun. The vaccine, known as mRNA-1273, was co-developed by the Cambridge, Massachusetts-based biotechnology company Moderna and… Read More

#Covid-19 #News

#Cell therapy #Clinical trials #Gene therapy #Oncology #Preclinical

Collaboration to investigate IMM-101 in difficult to treat cancers

This will explore clinical trials with IMM-101, in combination with other treatments, in difficult to treat cancers, with a particular focus on epithelial cancers such as pancreatic cancer and sarcoma. Immodulon, an immuno-oncology company, and the Champalimaud Foundation, a private, non-profit, research organisation in Lisbon, Portugal, have announced… Read More

#Cancer Research #News

#Cell therapy #Drug development #Drug discovery #Gene therapy #Genetics / genomes #Immunology #Regulatory #RNA #Stem cells

How the regulator is regulated: insight on immune-related protein holds therapeutic value

Image: National Cancer Institute Scientists unravel how the immune checkpoint protein PD-L2 is regulated, which has potential implications in immune therapy Various proteins expressed in cells of the immune system have shown to play an important role in various disorders, including cancer, allergy, and autoimmune disease. In a… Read More

#News

#Academic #Assay development optimisation & technology #Business #Cell therapy #Cellular assays #Chemical engineering #Clinical trials #Drug development #Drug discovery #Enabling technologies #Gene editing #Gene therapy #Genomics #High Content Screening #High throughput screening #Imaging #Lead discovery #Microfluidics #Oncology #RNA #Screening #Stem cells #Therapeutics #Toxicology #Translational #Translational chemistry

Merging two immunotherapies may be more effective treatment against some cancers

Some of the most promising advances in cancer treatment have centred on immunotherapies that rev up a patient’s immune system to attack cancer. However, immunotherapies don’t work in all patients, and researchers have been searching for ways to increase their effectiveness. Now, researchers at Washington University School of… Read More

#Cancer Research #News

#Cell therapy #Drug development #Drug discovery #Drug targets #Gene therapy #Lead discovery #Oncology #Preclinical #RNA #Stem cells

Researchers ID new target in drive to improve immunotherapy for head and neck cancer

Researchers at the UCLA Jonsson Comprehensive Cancer Center and UCLA School of Dentistry have identified a potential new combination therapy to treat advanced head and neck squamous cell carcinoma, the most common type of head and neck cancer. A study in mice found that using an anti-PD1 immunotherapy… Read More

#Cancer Research #News

#Analysis #Business #Cell therapy #Clinical trials #Drug development #Drug discovery #Gene therapy #High throughput screening #Imaging #Mass spectrometry / NMR #Microbiology #Screening #System biology #Target validation

Avacta updates on clinical validation of Adeptrix COVID-19 diagnostic test

Image: Pille-Riin Priske Avacta has begun work with the UK government’s CONDOR programme to evaluate and clinically validate the high throughput COVID-19 bead-assisted mass spectrometry (BAMS) laboratory assay developed with Adeptrix. The COVID-19 National Diagnostic Research and Evaluation Platform (CONDOR), recently funded by the National Institute for Health… Read More

#Covid-19 #News

#AI / data analytics / healthtech / informatics #Cell therapy #Computational chemistry #Drug discovery #Gene therapy #Lead discovery #Oncology #RNA #Stem cells #Therapeutics

Immune system could be trained to spot drug-resistant cancers

Aggressive cancers could be treated with immunotherapies that direct the immune system to kill cancer cells with specific drug resistance-causing mutations, a major new study suggests. Drug resistance mutations which restore activity of the BRCA1 or BRCA2 genes as a way of avoiding the effects of drug treatment… Read More

#Cancer Research #Covid-19 #News

#Cell therapy #Drug discovery #Gene therapy #Genetics / genomes #Immunology #Lead discovery #Oncology #Regenerative Medicine #RNA #Stem cells #Therapeutics

Fine-tuning adoptive cell therapy could create more efficient immunotherapies

23 July 2020 Image: National Cancer Institute Adoptive cell transfer immunotherapy is one of the most promising new treatments for people with hard-to-treat cancers. However, the process is complex and needs fine-tuning in order to develop more treatment strategies that will work for more people. In a new… Read More

#News

#Biologics / Biotechnology #Business #Cell therapy #Clinical specialities #Clinical trials #Drug development #Drug discovery #Enabling technologies #Gene therapy #Immunology #Immunology / Virology & Vaccines #Precision medicine #RNA #Therapeutics

Over £100m UK cash boost to produce millions of doses of COVID-19 vaccine

The UK’s capability to manufacture vaccines has received a substantial boost, as the UK government has announced an additional £100 million to ensure that any successful COVID-19 vaccine can be produced at scale in the UK. The investment will fund a Cell and Gene Therapy Catapult Manufacturing Innovation… Read More

#Covid-19 #News

#AI / data analytics / healthtech / informatics #Business #Cell therapy #Drug discovery #Gene therapy #Target validation

Thermo Fisher Scientific looks to speed up cell and gene manufacturing

22 July 2020 Image: ThisisEngineering RAEng Thermo Fisher Scientific’s latest launch has been designed to allow fast cGMP-compatible cell and gene therapy manufacturing. Developed as the first-ever all-inclusive solution to simplify and optimise the cGMP equipment installation and validation process, the Thermo Scientific Cell Therapy Systems (CTS) Series… Read More

#News